FULCRUM THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $95.2M | $57.1M |
| FY2021 | — | $211.5M | $35.4M |
| FY2022 | — | $198.9M | $35.1M |
| FY2023 | — | $235.2M | $25.6M |
| FY2024 | — | $243.0M | $58.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $95.2M | $57.1M |
| FY2021 | — | $211.5M | $35.4M |
| FY2022 | — | $198.9M | $35.1M |
| FY2023 | — | $235.2M | $25.6M |
| FY2024 | — | $243.0M | $58.2M |